Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC37A4 | O43826 | 7/20 | 0.58 |
| ▸ | ITGA2 | P17301 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | RECQL | P46063 | 2/20 | 0.52 |
| ▸ | ELANE | P08246 | 2/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.49 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.49 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.49 |
| ▸ | PSMA1 | P25786 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28549227 | 0.89 | SLC37A4 (0.69) | SLC37A4MEN1KMT2AALDH1A1MAPT | |
| Aloesaponarin I SCHEMBL29657074 | 0.89 | ITGA2 (0.57) | SLC37A4ITGA2MEN1KMT2AALDH1A1 | |
| Aloesaponarin I SCHEMBL13317456 | 0.89 | ITGA2 (0.57) | SLC37A4ITGA2MEN1KMT2AALDH1A1 | |
| SCHEMBL16225976 | 0.85 | EGFR (0.56) | SLC37A4ITGA2MEN1KMT2AELANE | |
| SCHEMBL19452223 | 0.85 | EPHX2 (0.48) | SLC37A4ITGA2MEN1KMT2AALDH1A1 | |
| SCHEMBL19449184 | 0.83 | ELANE (0.60) | SLC37A4ITGA2MEN1KMT2AALDH1A1 | |
| SCHEMBL16226021 | 0.83 | JUN (0.65) | SLC37A4ITGA2MEN1KMT2AALDH1A1 | |
| SCHEMBL3190559 | 0.82 | MEN1 (0.58) | SLC37A4MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL8976464 | 0.82 | MAPT (0.46) | SLC37A4MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL2958068 | 0.79 | ELANE (0.49) | SLC37A4MEN1KMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140335050-A1 | METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER | THE GENERAL HOSPITAL CORPORATION (US) | 2014-11-13 | — | — | US | disclosed |
| US-7737084-B2 | Image fading preventing agent, image forming element, recording medium, image forming method and image | CANON KABUSHIKI KAISHA (JP) | 2010-06-15 | — | — | US | disclosed |
| US-7737084-B2 | Image fading preventing agent, image forming element, recording medium, image forming method and image | CANON KABUSHIKI KAISHA (JP) | 2010-06-15 | — | — | US | disclosed |
| US-20070093386-A1 | IMAGE FADING PREVENTING AGENT, IMAGE FORMING ELEMENT, RECORDING MEDIUM, IMAGE FORMING METHOD AND IMAGE | CANON KABUSHIKI KAISHA (JP) | 2007-04-26 | — | — | US | disclosed |
| US-20070093386-A1 | IMAGE FADING PREVENTING AGENT, IMAGE FORMING ELEMENT, RECORDING MEDIUM, IMAGE FORMING METHOD AND IMAGE | CANON KABUSHIKI KAISHA (JP) | 2007-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140335050-A1 | METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER | IL2RA, CD74, IL2 | SLC37A4 4856/4885ITGA2 793/4885MEN1 4777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.